• News
  • SAN DIEGO
  • BioTech

Seragon names Debasish Roychowdhury acting chief medical officer

San Diego-based Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, announced the expansion of the company's Clinical and Scientific Advisory Board (CSAB) and the appointment of Debasish Roychowdhury, M.D., who will serve as Seragon's acting chief medical officer.

Roychowdhury has a strong background in research and development, regulatory and commercial operations in the oncology field, having previously served in senior leadership roles at Sanofi, GlaxoSmithKline and Eli Lilly and Co. He joins the founding members of the Seragon CSAB that includes academic scientists Charles Sawyers, M.D., Jose Baselga, M.D., Ph.D., and Ronald M. Evans, Ph.D.

Roychowdhury most recently served as senior vice president of global oncology and head of the global oncology division at Sanofi from August 2009 to September 2013. Prior to that, he served as the vice president for clinical development at GlaxoSmithKline (NYSE: GSK) since 2005. In 2008, he was a member of the team that created GSK's new Oncology R&D Unit. Roychowdhury also served in oncology clinical research and later in regulatory affairs for Eli Lilly and Co. (NYSE: LLY).

During his tenure in industry he was involved in the approval of nine drugs, including, Alimta, Tykerb and Jevtana.

Prior to his role in industry, he served as faculty member at the University of Cincinnati, where he directed a number of clinical programs. He moved to the United States in 1989 where he specialized in internal medicine, hematology and oncology at the University of California at San Francisco. Dr. Roychowdhury received his Doctorate of Medicine from the All India Institute of Medical Sciences, New Delhi.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.